B-CELL LYMPHOPROLIFERATIVE DISORDER
Clinical trials for B-CELL LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody therapy offers hope for rare blood cancer patients
Disease control Recruiting nowThis study tests a drug called epcoritamab in 20 people with Waldenstrom macroglobulinemia, a rare blood cancer, that has already been treated. The drug is a type of antibody that helps the immune system attack cancer cells. The main goal is to see how many patients respond to th…
Matched conditions: B-CELL LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Gottfried von Keudell, MD PhD • Aim: Disease control
Last updated May 26, 2026 09:57 UTC
-
New hope for rare blood cancer: pacritinib trial opens
Disease control Recruiting nowThis study tests a drug called pacritinib in 30 people with Waldenström macroglobulinemia whose cancer returned or did not respond to prior treatment. The goal is to see if the drug can shrink tumors and improve symptoms. Participants take the drug by mouth and are monitored for …
Matched conditions: B-CELL LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated May 18, 2026 12:04 UTC